Elanix Biotechnologies
OverviewSuggest Edit
Elanix Biotechnologies develops and commercializes products for acute wound care, dermatological and gynecological applications. The Company develops and markets progenitor cell-based products that are used to regenerate tissue and promote healing in the treatment of burns, and gynecological and dermatological conditions. Its products include GYNrepair, a cream for genital external mucosa, and SKINrepair, a cream for skin that protects against external aggressions. Elanix Biotechnologies is also developing FirstCover, an acute wound care tissue engineering product that is used to provide protection and healing for burns, and trauma and plastic surgery. The Company offers cell technology services as well.
| Type | Public | |
| Founded | 2012 | |
| HQ | Frankfurt am Main, DE | Map |
| Website | elanixbiotechnologies.ch |
Key People/Management at Elanix Biotechnologies
Tomas J. Svoboda
Elanix Biotechnologies Office Locations
Elanix Biotechnologies Financials and Metrics
Elanix Biotechnologies Revenue
| EUR | |
|---|---|
Revenue (H1, 2019) | 3.0k |
Gross profit (H1, 2019) | 103.0k |
Net income (H1, 2019) | (609.0k) |
EBITDA (H1, 2019) | (207.0k) |
EBIT (H1, 2019) | (213.0k) |
Market capitalization (27-Apr-2022) | 4.3m |
Closing stock price (27-Apr-2022) | 0.2 |
Cash (30-Jun-2019) | 39.0k |
EV | 4.3m |
| EUR | FY, 2018 |
|---|---|
Revenue | 62.0k |
Cost of goods sold | (281.0k) |
Gross profit | (213.0k) |
R&D expense | (321.0k) |
| EUR | H1, 2019 |
|---|---|
Revenue | 3.0k |
Gross profit | 103.0k |
R&D expense | (4.0k) |
| EUR | FY, 2018 |
|---|---|
Cash | 20.0k |
Accounts Receivable | 30.0k |
| EUR | H1, 2019 |
|---|---|
Cash | 39.0k |
Accounts Receivable | 26.0k |
| EUR | FY, 2018 |
|---|
| EUR | H1, 2019 |
|---|
Elanix Biotechnologies Revenue Breakdown
Elanix Biotechnologies revenue breakdown by business segment: 100.0% from COSMETIC CREAMS
Elanix Biotechnologies Cybersecurity Score
Elanix Biotechnologies Online and Social Media Presence
31 Twitter followers
Elanix Biotechnologies has 31 Twitter Followers. The number of followers has decreased 1% quarter over quarter
Elanix Biotechnologies's Trends
Elanix Biotechnologies Blogs
NOVEMBER BUSINESS UPDATE (ENG, DE, FR)
October Business Update (ENG, DE, FR)
Elanix Biotechnologies Frequently Asked Questions
When was Elanix Biotechnologies founded?
Elanix Biotechnologies was founded in 2012.
Who are Elanix Biotechnologies key executives?
Elanix Biotechnologies's key executives are Tomas J. Svoboda.
How many employees does Elanix Biotechnologies have?
Elanix Biotechnologies has 11 employees.
What is Elanix Biotechnologies revenue?
Latest Elanix Biotechnologies annual revenue is €62 k.
What is Elanix Biotechnologies revenue per employee?
Latest Elanix Biotechnologies revenue per employee is €5.6 k.
Who are Elanix Biotechnologies competitors?
Competitors of Elanix Biotechnologies include E-Qure, InspireMD and Soligenix.
Where is Elanix Biotechnologies headquarters?
Elanix Biotechnologies headquarters is located at Hanauer Landstraße 291B, Frankfurt am Main.
Where are Elanix Biotechnologies offices?
Elanix Biotechnologies has offices in Frankfurt am Main, Epalinges and Nyon.
How many offices does Elanix Biotechnologies have?
Elanix Biotechnologies has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies